RxDoctor Payments Data

Larry Doughty, MD

Pain Medicine · Alexandria, LANPI 1922549211

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,843 of the $3,061 with a category attached, or 60.2%. 4 manufacturers reported payments, led by Boston Scientific at 52.0% of the total. Reporting peaked in 2024 at $1,283 and has fallen 94.0% since, to $76 in 2025. That places this record below the midpoint for pain medicine clinicians in LA, where the typical reported total is $3,650.

$3,061in general payments, 2019–2025

Across 22 payments — averaging $139.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Stryker$1K
  • Medtronic$111
  • Spinal Simplicity, LLC$15

What the payments were for

  • Travel & lodging$1,84360%
  • Food & beverage$1,21740%

General payments by program year

20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific12$1,590
Stryker8$1,344
Medtronic1$111
Spinal Simplicity, LLC1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,061 in reported general payments places this provider in the 45th percentile of 97 pain medicine providers in Louisiana.

See all pain medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$401,019
Medicare patients
812
Services billed
4,942

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin168$3,321
Pregabalin142$1,809
Tizanidine Hcl200$948
Celecoxib35$198
Cyclobenzaprine Hcl12$169
Methylprednisolone21$118
Tramadol Hcl14$69
Meloxicam17$20
Lorazepam26$14

Paid to pharmacies, not to this prescriber.

Other pain medicine in Alexandria

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →